| |
Article Title |
Author(s) |
Type |
Pages |
|
|
TCT-1: Mortality with Primary Angioplasty when paramedics transport patients directly from the Field to a Cardiac Center Compared to when paramedics transport patients to the Nearest Emergency Department
|
|
Abstract
|
page 1D
|
|
|
TCT-2: Presentation at a Non PCI Facility Requiring Transfer Does NOT Worsen Long-term Prognosis in Patients With STEMI Undergoing Primary Angioplasty. The HORIZONS-AMI Trial
|
|
Abstract
|
page 1D
|
|
|
TCT-3: Maintenance of Long-Term Clinical Benefit with Sirolimus-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction: Three-Year Results of the SESAMI Trial
|
|
Abstract
|
page 2D
|
|
|
TCT-4: ST-Elevation Myocardial Infarction (STEMI) due to Stent Thrombosis: A New and Enlarging Subgroup of High Risk Patients
|
|
Abstract
|
page 2D
|
|
|
TCT-5: Impact Of Thrombus On Clinical Outcomes Of Patients With Stemi Undergoing Primary Pci: Analysis From The Horizons-ami Trial
|
|
Abstract
|
pages 2D-3D
|
|
|
TCT-6: ST-Segment Recovery at Last Contrast Injection Accurately Predicts Five-Year Mortality in Patients After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
|
|
Abstract
|
page 3D
|
|
|
TCT-7: Impact of Thrombus Aspiration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Analysis from the HORIZONS-AMI Trial
|
|
Abstract
|
pages 3D-4D
|
|
|
TCT-8: Comparison Of Safety and Efficacy Of Intracoronary Bolus Abciximab Only Versus Standard Intravenous Bolus and Infusion Abciximab In Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
|
|
Abstract
|
page 4D
|
|
|
TCT-9: Five Year Outcomes In the Early Invasive Versus Selective Invasive Management for Non-ST-Elevation Acute Coronary Syndromes (ICTUS) Trial
|
|
Abstract
|
page 4D
|
|
|
TCT-10: Bivalirudin versus Heparin Plus Glycoprotein Inhibitors In Patients With Acute Coronary Syndromes And Prior Coronary Artery Bypass Grafting: Analysis From The Acuity Trial
|
|
Abstract
|
page 5D
|
|
|
TCT-11: Validity of the GRACE (Global Registry of Acute Coronary Events) Acute Coronary Syndrome Prediction Model for 30 day Mortality in Patients > 75 years
|
|
Abstract
|
page 5D
|
|
|
TCT-12: Comparison Of Safety And Efficacy Of Intracoronary Bolus Abciximab Only Vs Standard Intravenous Bolus And Infusion Abciximab In Patients With Myocardial Infarction Undergoing Percutaneous Coronary Intervention
|
|
Abstract
|
pages 5D-6D
|
|
|
TCT-13: Is Further Clopidogrel Loading Required Pre-PCI in Patients Presenting with Non-ST-segment Elevation Acute Coronary Syndromes on Chronic Clopidogrel Therapy?
|
|
Abstract
|
page 6D
|
|
|
TCT-14: Improved Short and Long Term Survival with Abciximab Use During Revascularisation Post NSTEMI is Seen Only In Patients Under 75
|
|
Abstract
|
page 6D
|
|
|
TCT-15: Individual Patient Risks Of Major Bleeding And Myocardial Infarction And Their Implications For Mortality And For Treatment Choice In Acute Coronary Syndromes: Findings From The ACUITY Trial
|
|
Abstract
|
pages 6D-7D
|
|
|
TCT-16: Natural History of Tako-tsubo Cardiomyopathy
|
|
Abstract
|
page 7D
|
|
|
TCT-17: Analysis of outcomes after repeat revascularization: Analysis from the SYNTAX Trial
|
|
Abstract
|
page 7D
|
|
|
TCT-18: Prognostic Impact of Staged vs. “One-Time” Intervention for Multivessel Disease During Primary PCI in STEMI: Insights from the HORIZONS-AMI Trial
|
|
Abstract
|
page 8D
|
|
|
TCT-19: Five-year Clinical Outcomes of the Arterial Revascularization Therapies Study Part 2 Of the Sirolimus-eluting Stent In the Treatment Of Patients with Multivessel de novo Coronary Artery Lesions
|
|
Abstract
|
page 8D
|
|
|
TCT-20: Syntax Score Revisited: New Assessment Of The Syntax Score Reproducibility
|
|
Abstract
|
pages 8D-9D
|
|
|
TCT-21: Percutaneous Coronary Interventions versus Surgical Revascularization in the management of Acute Coronary Syndrome. Sub Analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial
|
|
Abstract
|
page 9D
|
|
|
TCT-22: Outcomes of Coronary Artery Bypass Grafting Compared with Percutaneous Coronary Intervention in Patients with Multi-Vessel Coronary Disease
|
|
Abstract
|
page 9D
|
|
|
TCT-23: Single-vessel Or Multi-vessel PCI in Patients With Multi-vessel Disease Presenting Non-ST Elevation Acute Coronary Syndromes
|
|
Abstract
|
page 10D
|
|
|
TCT-24: Analysis of Stroke Occurring in the SYNTAX Trial
|
|
Abstract
|
page 10D
|
|
|
TCT-25: Clinical Implication of Different Plaque Distribution Patterns in Distal Left Main Coronary Artery
|
|
Abstract
|
page 11D
|
|
|
TCT-26: Five-Year Durability of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries Compared with Bare Metal Stents: Multicenter Registry in Asia
|
|
Abstract
|
page 11D
|
|
|
TCT-27: Systematic Double Stenting versus Simple Provisional T-stenting for True Bifurcation Lesions of Left Main Coronary Artery Disease Using Drug-Eluting Stents: Multicenter Registry in Asia
|
|
Abstract
|
pages 11D-12D
|
|
|
TCT-28: Does the SYNTAX Score Predict Outcome Following PCI to the Left Main Coronary Artery in the Real World?
|
|
Abstract
|
page 12D
|
|
|
TCT-29: Five Year Outcomes Following PCI with DES Implantation vs CABG for Unprotected Left Main Coronary Artery Lesions: Milan Experience
|
|
Abstract
|
page 12D
|
|
|
TCT-30: Drug-Eluting Stents for the Treatment of Left Main coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus, BiolimusA9, EPC Capture and Everolimus-Elutting Stent: Multicenter Registry in Asia
|
|
Abstract
|
page 13D
|
|
|
TCT-31: Impact of Diabetes Mellitus on Mid-Term Results after Percutaneous Revascularization of Left Main Coronary Disease
|
|
Abstract
|
page 13D
|
|
|
TCT-32: Stent Endothelization after Paclitaxel Eluting Stent Implantation in Left Main: A 3 Years Intravascular Ultrasound and Optical Coherence Tomography Follow-up
|
|
Abstract
|
page 13D
|
|
|
TCT-33: Isolated PCI to the Proximal LAD: Long Term Follow Up Of DES Vs BMS
|
|
Abstract
|
page 14D
|
|
|
TCT-34: Comparison of Zotarolimus-Eluting Stents Versus Sirolimus-Eluting Stents And Paclitaxel-Eluting Stents for the Treatment of Very Long Lesions: A Subgroup Analysis of the ZEST Trial
|
|
Abstract
|
page 14D
|
|
|
TCT-35: Safety and Effectiveness Of Sirolimus-Eluting and Zotarolimus-Eluting Stents in Diabetic and Non-Diabetic Patients in Western Denmark
|
|
Abstract
|
pages 14D-15D
|
|
|
TCT-36: Derivation and Validation of a Risk Model for Predicting Clinically-Driven Target Lesion Revascularization in Drug Eluting Stents
|
|
Abstract
|
page 15D
|
|
|
TCT-37: Long-Term Safety and Clinical Efficacy Outcomes of the Paclitaxel-Eluting Stent from a Patient-Level Pooled Analysis of the TAXUS Clinical Trials
|
|
Abstract
|
pages 15D-16D
|
|
|
TCT-38: 3-year Clinical Follow-up on a Large Cohort of ‘Full-Metal Jacket’ PCI Procedures
|
|
Abstract
|
page 16D
|
|
|
TCT-39: Late “Catch-up” in Target Vessel Revascularization with Drug Eluting Stents vs Bare Metal Stents in Saphenous Vein Graft Intervention: Two Year Results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group
|
|
Abstract
|
page 16D
|
|
|
TCT-40: Stent Thrombosis Free Survival up to 7 Years in Patients Undergoing Drug-Eluting Stent (DES) Implantation in the Real-World Clnical Practice
|
|
Abstract
|
page 17D
|
|
|
TCT-41: Clinical Syndrome And Neovascularization In Non Culprit Coronary Atherosclerotic Plaques
|
|
Abstract
|
page 17D
|
|
|
TCT-42: Impact of Drug-eluting Stents on the Peristent Tissue Compositions: A Serial Volumetric Analysis Using Quantitative Integrated Backscatter Intravascular Ultrasound
|
|
Abstract
|
pages 17D-18D
|
|
|
TCT-43: Relation Between Plaque Type And Dissections At The Edges After Stent Implantation: An Optical Coherence Tomography Study
|
|
Abstract
|
page 18D
|
|
|
TCT-44: Impact of Lumen Narrowing Within Everolimus-Eluting Stents on Downstream Vessel Segments
|
|
Abstract
|
page 18D
|
|
|
TCT-45: Comparison of Neointimal Coverage of Drug Eluting Stents Between Diabetes and Non-diabetes Patients Using Optical Coherence Tomography at 9 Months After Implantation
|
|
Abstract
|
pages 18D-19D
|
|
|
TCT-46: Incomplete Stent Apposition And Delayed Tissue Coverage Are More Frequent In Drug Eluting Stents Implanted During Primary Percutaneous Coronary Intervention For ST Elevation Myocardial Infarction Than In Drug-Eluting Stents Implanted for Stable/Unstable Angina: Insights From Optical Coherence Tomography
|
|
Abstract
|
page 19D
|
|
|
TCT-47: Culprit Lesions Located In The Proximal Segments of the Coronary Arteries Have Thinner Fibrous Cap and Greater Incidence of Plaque Rupture. An Optical Coherence Tomography Study
|
|
Abstract
|
page 19D
|
|
|
TCT-48: Resting Pd/Pa Measured With Pressure Wire Strongly Correlates With Fractional Flow Reserve
|
|
Abstract
|
page 20D
|
|
|
TCT-49: Transcranial Doppler Monitoring During Carotid Artery Stenting: Comparison between Flow Reversal and Filter for Cerebral Protection
|
|
Abstract
|
page 20D
|
|
|
TCT-50: In search for predictors of carotid plaque destabilization: Update from the Carotid Virtual Histology and Biomarkes (CRACK-VH) Study
|
|
Abstract
|
page 21D
|
|
|
TCT-51: Carotid angioplasty and stenting in octogenarians. Is it safe?
|
|
Abstract
|
page 21D
|
|
|
TCT-52: Hybrid Approach to “Type A” Aortic Dissection: Second Endovascular Stage is Safer After Implantation Of a New Multibranched Dacron Graft to Obtain a “Fixed” Elephant Trunk
|
|
Abstract
|
pages 21D-22D
|
|
|
TCT-53: Retrograde Ascending Aortic Dissection During or After Thoracic Aortic Stent-Graft Placement- Insights from the European Registry on Endovascular Aortic Repair Complications (EuREC)
|
|
Abstract
|
page 22D
|
|
|
TCT-54: Predictors of Clamping Intolerance during Carotid Artery Stenting using Proximal Protection
|
|
Abstract
|
page 22D
|
|
|
TCT-55: Midterm Outcome of Inoue Stent Graft for the Treatment of Thoracic Aortic Aneurysm and Dissections
|
|
Abstract
|
page 23D
|
|
|
TCT-56: Endovascular Repair of Traumatic Thoracic Aortic Tears is the Preferred First Line Therapy
|
|
Abstract
|
page 23D
|
|
|
TCT-57: Baseline Inflammatory Status And Long-term Changes In Renal Function After Percutaneous Renal Artery Stenting: A Prospective Study
|
|
Abstract
|
page 24D
|
|
|
TCT-58: Directional Atherectomy is Superior to Percutaneous Transluminal Angioplasty (PTA) for the Endovascular Treatment of Complex Tibial Lesions
|
|
Abstract
|
page 24D
|
|
|
TCT-59: Orbital Atherectomy In Treatment Of Peripheral Arterial Occlusive Disease Below The Knee: A Large Single Center Experience
|
|
Abstract
|
pages 24D-25D
|
|
|
TCT-60: Lower extremity Atherectomy versus Percutaneous Transluminal Angioplasty in the Diabetic Patient
|
|
Abstract
|
page 25D
|
